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Background: Advancements in running shoe technology, particularly in the Nike Vaporfly, have 
been shown to improve running economy. Other brands have now also developed new, advanced 
shoes with a carbon-fiber plate and thicker, new midsole foams. However, none of these new 
shoes have been compared to the Vaporfly. Therefore, we compared the effects of 7 different 
carbon-plated shoes and 1 traditional racing shoe on running economy.  
Methods: Seven carbon-plated shoes: Hoka-RocketX (HRX), Saucony-Endorphin Pro (SEP), 
Nike-Alphafly (NAF), Asics-Metaspeed Sky (AMS), Nike-Vaporfly2 (NVF2), New Balance-RC 
Elite (NBRC), Brooks-Hyperion Elite2 (BHE2), and one traditional shoe: Asics-Hyperspeed 
(AHS) were tested in 12 male runners (5k best: 16.0±0.7 min) on two visits. Shoes were tested in 
a random sequence over 8x5-minute trials (16 km‧hr-1; 5-minute rest between trials) on visit 1, 
and in the reverse/mirrored order for visit 2. Metabolic and running mechanics data were 
collected and averaged across visits.  
Results: VO2 (ml‧kg
-1‧min-1; % change from AHS) was significantly different across shoes. HRX 
(51.67±2.07) and BHE2 (51.42±1.72) did not differ from AHS (51.71±2.02). While SEP 
(50.93±1.82; -1.48±0.72%) and NBRC (50.99±1.83; -1.37±0.78%) were statistically better than 
AHS, they were inferior to NAF (50.13±1.86; -3.03±1.48%), NVF2 (50.29±1.72; -2.72±1.02%), 
and AMS (50.39±1.71; -2.52±1.08%). 
Conclusions: While some of the shoes tested performed better than the traditional racing shoe, 
only NAF and AMS matched the NVF2. From these data, it appears the running shoe market as a 
whole has not caught up to the advantages conferred by the NVF2. 
Keywords: distance running, endurance performance, road racing, super shoes  





The advent of the carbon-plated running shoe, in support of the historic sub 2-hour 
marathon by Nike athlete Eliud Kipchoge, has resulted in an arms race across various running 
shoe companies in hopes of providing a similar competitive advantage to their athletes and 
customers. These new “super” shoes are characterized by the presence of a carbon-fiber plate in 
the midsole of the shoe to increase stiffness, often along with new, more responsive and thicker 
midsole foams to provide cushioning and enhance energy return. These advancements are 
purported to enhance performance by improving running economy (RE), a measure of oxygen 
consumption or energy utilization at a given physical workload. RE is a key determinant of 
endurance performance, as enhanced economy is indicative of a reduced energy cost to run at a 
given speed, or the ability to run at faster speeds while working at the same physiological 
intensity.1, 2  
Recent analysis by Bermon et al.3 concluded that advancements in running shoe 
technology contributed substantially to improvements in top times internationally in the 
marathon and half marathon among elites from 2016 to 2019. Similarly, Senefeld et al.4 showed 
a 2% (2.8 minute) and 2.6% (4.3 minute) improvement in elite marathon race times for men and 
women, respectively, running at the world marathon majors in new Nike shoe technology 
(Vaporfly and Alphafly). An earlier analysis by the New York Times5 concluded performance 
benefits were also conferred across a broader range of sub-elite runners, specifically in the Nike 
Vaporfly. While these observational, retrospective studies point towards widespread 
improvements in performance, much of the evidence is centered on the Nike Vaporfly and 
Alphafly shoes.   




Similarly, there is both a scarcity of controlled, laboratory-based research on these new 
shoe advancements, and it is limited almost entirely to new Nike shoes. As early as 2014, 
Worobets et al.6 showed that more compliant and resilient midsole foams made of thermoplastic 
polyurethane (TPU) improved RE by ~1% compared to traditional ethylene vinyl acetate (EVA) 
foam in an Adidas prototype without a carbon-fiber plate. However, much of the research since 
has been limited to various editions of the Nike Vaporfly, which incorporates new, thicker 
midsole foams made of polyether block amide (PEBA) and a full-length carbon-fiber plate.7-10 
Hoogkamer et al.7 found ~4% improvements in RE in a Nike Vaporfly prototype across running 
speeds of 14-18 km·h-1, which was independently confirmed by Barnes and Kilding8. In addition 
to the increased longitudinal bending stiffness provided by the carbon-fiber plate in these shoes, 
the new midsole foam in the Nike Vaporfly was more compliant and resilient, returning more 
mechanical energy following compression.7 This was thought to allow for the observed 
improvements in RE. 
While those results suggest the shoes do offer a substantial advantage, it raises the 
question of whether or not this provides an unfair advantage.11 Given these concerns, some 
suggestions have been made on the regulation of these new shoes,12, 13 and World Athletics did 
rule in 2020 on new technical specifications, limiting the stack height/foam thickness to 40 mm 
for road racing and limiting shoes to a single carbon-fiber plate.14 Since the release of the Nike 
Vaporfly, most major running shoe brands have come to market with a carbon-plated shoe of 
their own, with or without new proprietary midsole foams. The shoes have been promoted not 
just for their elite, sponsored athletes, but marketed across the ranks of competitive running. 
However, to our knowledge no comparative data has been published. That is to say, the Nike 
Vaporfly has been compared to traditional racing shoes, but not to any of its new competitors on 




the market. Should these advanced shoes produced now by other companies be shown to offer 
similar improvements in RE, things might be deemed more equitable. In the absence of any 
empirical evidence, we are forced to operate on the assumption that the playing field has been 
more or less leveled by the rest of the running shoe industry. Anecdotal evidence of large 
numbers of athletes gravitating towards one or two shoe brands/models,15 athletes breaking 
sponsorship contracts to run in Nike shoes, or even sponsors allowing athletes to run in different 
brands so as to not hold their athletes back,16 suggest that this is not a safely held assumption. 
Case-study data from our laboratory would suggest this as well, as the Nike Alphafly was shown 
to improve economy by 4%, not just relative to a traditional racing shoe, but to one of its carbon-
plated competitor shoes as well.17  
We do not necessarily think it is feasible or a good long-term approach to expect to test 
every new shoe that comes to market to determine if certain shoes are providing a potential 
advantage relative to its competitors. However, we do think that given the rapid advancements in 
running shoe technology over the last few years, coupled with the lack of any comparative 
research across various carbon-plated running shoes, an initial comparison across the broad 
landscape of the major brands in the running shoe industry is warranted and overdue. Therefore, 
the purpose of this study was to compare the effects of 7 different carbon-plated racing shoes and 
1 traditional racing shoe on running economy in competitive, male distance runners.  
2. Materials and methods 
2.1. Subjects 
Twelve trained, male distance runners who met the following inclusion criteria were 
recruited for the study: 1) run training of at least 3 runs per week for previous 3 months, 2) sub-
17:30 5-km race performance, or equivalent race performance for distances 3 km to marathon, 




within the last year, 3) shoe size between 10-11 US men’s sizing. Performance criteria was set so 
that subjects should be able to run below the lactate threshold at the tested RE speed of 16 km‧hr-
1. This was also confirmed by blood lactate measures, as described in the experimental design 
section (2.2). Subject demographics (n = 12) were as follows (mean ± standard deviation), age: 
26 ± 8 years, height: 181 ± 5 cm, body mass: 68.0 ± 3.3 kg, body fat: 14.0 ± 2.2%, 5-km personal 
best: 16.0 ± 0.7 minutes, 5-km season best within last year: 16.4 ± 0.9 minutes. This study was 
approved by the Stephen F. Austin State University Institutional Review Board (2021-21220) 
and conducted in accordance to the ethical standards in the Declaration of Helsinki. Informed 
consent was obtained from all subjects prior to participation. 
2.2. Experimental design 
Subjects reported to the lab for 2 visits on separate days. On each visit, subjects ran in all 
8 of the shoes (7 carbon-plated shoes and 1 traditional racing shoe). On visit 1, the test sequence 
of the shoes was randomized for each subject using a random number generator. Each subject 
tested the shoes in the reverse/mirrored order on visit 2. Subjects were asked to avoid exercise, 
caffeine, and alcohol within 24 hours of their testing visits. Additionally, they were asked to 
recall what they ate prior to visit 1 and to replicate this as much as possible for visit 2.  
2.2.1. Shoes 
Seven carbon-plated racing shoes were tested: 1) Hoka One One – Rocket X (Hoka RX), 
2) Saucony – Endorphin Pro (Saucony EP), 3) Nike – Air Zoom Alphafly Next% (Nike AF), 4) 
Asics – Metaspeed Sky (Asics MS), 5) Nike – ZoomX Vaporfly Next% 2 (Nike VF2), 6) New 
Balance – Fuel Cell RC Elite (New Bal RC), 7) Brooks – Hyperion Elite 2 (Brook HE2) and 1 
traditional racing shoe 8) Asics – Hyperspeed (Asics HS). Shoe specifications are provided in 
Table 1 and images in Figure 1. These shoes were selected as they represent the top carbon-




plated racing shoes offered by many of the major brands in the running shoe industry. While we 
were not able to obtain every major carbon-plated racing shoe on the market due to product 
availability and funding limitations, we feel that the lineup obtained and tested achieved the 
broad goal of assessing whether or not the competitive running shoe landscape has been 
normalized relative the previous benefits shown to be offered by the Nike Vaporfly. To limit the 
effect of shoe mass on RE, the average mass of the shoes tested was 225 g and none of the tested 
shoes differed in mass by more than 30 g. Further, all 7 carbon-plated shoes were within 18 g of 
the traditional shoe (Asics HS). The Asics HS is the same racing shoe Ryan Hall wore for his 
still-standing, 59:43 North American half-marathon record at the Aramco Houston Half-
Marathon in January 2007. All shoes were new at the beginning of the study and had not been 
run in previously. No shoe accumulated more than 22 km of distance during the study.  
Table 1 















Asics Metaspeed Sky 209 Yes 38 33 5 250 
Nike ZoomX Vaporfly Next% 2 211 Yes 40 32 8 250 
New Balance Fuel Cell RC Elite 221 Yes 34 24 10 225 
Hoka RocketX 224 Yes 35 30 5 180 
Asics Hyperspeed 227 No 30 21 9 90 
Brooks Hyperion Elite 2 229 Yes 35 27 8 250 
Saucony Endorphin Pro 239 Yes 39 31 8 200 
Nike Air Zoom Alphafly Next% 240 Yes 40 36 4 275 
Shoe mass represents average mass of the size 10, 10.5, and 11 shoes in the testing lineup. Stack height values 
obtained from shoe specifications listed on runningwarehouse.com. Retail prices reflect standard price listing at 
time of study.  
 





Fig. 1 Shoes tested included 7 carbon-plated racing shoes: A) Hoka One One Rocket X, B) Saucony Endorphin Pro, 
C) Nike Air Zoom Alphafly Next%, D) Asics Metaspeed Sky, E) Nike ZoomX Vaporfly Next% 2, F) New Balance 
Fuel Cell RC Elite, G) Brooks Hyperion Elite 2, and one traditional racing shoe: H) Asics Hyperspeed 
 
2.2.2. Test procedures 
 On visit 1, subjects first tried on all shoes to ensure proper sizing. Prior to beginning the 
RE testing trials, all subjects completed a 10-minute warmup jog in their own shoes at a self-
selected pace slower than 16 km‧hr-1. Subjects then completed 8 x 5-minute trials at 16 km‧hr-1 
wearing a different, randomly selected shoe for each trial. There was a 5-minute rest between 
trials to change shoes. All run testing was performed on a motorized treadmill (PPS 55 Med, 
Woodway, Waukesha, WI) and running speed was confirmed by a handheld digital tachometer 
(Peak-Meter PM6208A, Shenzhen, China). Oxygen consumption (VO2), carbon dioxide 
production, ventilation, and the respiratory exchange ratio (RER) was measured throughout each 
trial using a calibrated metabolic cart (TrueOne 2400, Parvo Medics, Sandy, UT), and the 
average values in the final 2 minutes of each 5-minute trial was used to determine economy. 
Energy expenditure was determined with non-protein based RER equations.18  




Running mechanics (ground contact time, cadence, ground contact time imbalances, 
vertical oscillation) and heart rate were also measured throughout each trial using a previously 
validated19 heart rate monitor with a built-in accelerometer (HRM Tri/920 XT, Garmin, Olathe, 
KS). Garmin FIT files were uploaded for analysis (Golden Cheetah, v3.4). Average stride length 
was determined as treadmill running speed divided by average stride rate. As previously 
described,20 ground contact time imbalance was calculated as the average, absolute difference in 
the percentage of ground contact time spent on the left vs. right foot, and the vertical oscillation 
ratio was calculated by dividing vertical oscillation by step length expressed as a percentage. The 
running mechanics data were averaged from the final 4.5 minutes of each 5-minute trial, and HR 
was averaged over the final minute.  
These procedures were identical for both RE testing visits and the average measures 
across the two visits was used for analysis. The shoe testing sequence was randomized for each 
subject on their first visit, and that shoe sequence was tested in reverse order for each subject’s 
second visit to eliminate any order effect. At the conclusion of the 8 trials, a capillary blood 
sample was obtained from the fingertip and analyzed (Lactate Plus, Nova Biomedical, Waltham, 
MA) to ensure the testing was performed below the onset of blood lactate accumulation (OBLA) 
of 4 mmol‧L-1.21 Body composition was assessed via dual-energy x-ray absorptiometry (GE 
Prodigy, Chicago, IL).  
2.3. Survey data 
 At the conclusions of visit 2, subjects completed a survey providing subjective feedback 
on the shoes. They were asked to rank the shoes in order of preference (most to least) for racing 
both 5 km and a marathon. Additionally, they rated each shoe on a 0- to 10-point scale for 




softness/cushioning (0-firm to 10-soft), energy return (0-less springy to 10-more springy), and 
stiffness (0-flexible to 10-rigid).  
2.4. Statistical analysis  
A repeated-measures ANOVA was used to compare shoe condition on the tested 
metabolic and mechanics variables. Continuous variables were inspected for normality and were 
normally distributed. Significant effects were followed up with pairwise comparisons with the 
Holm-adjustment for multiple comparisons.22 Significance for all statistical test was set with an α 
of 0.05. Based on the more conservative effect sizes (1.73) reported in previous literature9 
comparing the Nike VF to traditional racing shoes, an a priori power analysis (G*Power, 3.1.9.7, 
Universität Kiel, Germany) revealed a sample size of 10 subjects would be adequate to achieve a 
power of 0.8 with an α, adjusted for multiple pairwise comparisons (28 possible shoe 
comparisons), of 0.05. While we chose to adjust α by the full 28 potential shoe comparisons for 
the metabolic (VO2) data, we limited the pairwise shoe comparisons to just the Asics HS for all 
running mechanics variables (7 comparisons). Within subject effects sizes were calculated as the 
average of the individual subject difference scores divided by the standard deviation of the 
difference scores (Cohen’s dz).
23 Pearson correlations were determined between a shoe’s average 
VO2 and each running mechanics variable.  Non-parametric survey data was compared across 
shoes with Friedman tests with significant findings followed up with Conover’s post hoc tests 
with paired comparisons again limited to just the Asics HS. Spearman rank correlations were 
calculated between the average VO2 ranking for each shoe and the subjective survey data 
variables. All statistical analyses were performed using classical statistics in JASP (v0.14.1, 
University of Amsterdam, Netherlands).  
 





The average VO2 for each shoe along with the individual responses are displayed in 
Figure 2 and complete metabolic data in Table 2. There were significant differences across shoes 
for all metabolic variables.  
 
Fig. 2 Oxygen consumption (VO2) at 16 km‧hr-1 in 7 different carbon-plated racing shoes and one traditional racing 
shoe ranked from least (left) to most (right) economical. Black line depicts group average and grey lines depict 
individual responses. Abbreviations: AF = Alphafly; Bal RC = Balance RC Elite; EP = Endorphin Pro; HE2 = 
Hyperion Elite 2; HS = Hyperspeed; MS = Metaspeed Sky; RX = Rocket X; VF2 = Vaporfly 2.  
Follow up pairwise comparisons showed that compared to the traditional Asics HS shoe, 
the Hoka RX (-0.08%) and Brooks HE2 (-0.53%) did not significantly lower VO2. The New Bal 
RC (-1.37%), Saucony EP (-1.48%), Asics MS (-2.52%), Nike VF2 (-2.72%), and Nike AF (-
3.03) all significantly lowered VO2 (improved economy). However, the New Bal RC and 




Saucony EP  improved economy by less than 1.5% on average and were significantly worse than the Asics MS, Nike VF2, and Nike 
AF, which all resulted in greater than 2.5% improvements. Complete pairwise comparisons of each shoe to another is provided in 
Table 3. In terms of individual responsiveness, the percentage of subjects who responded with an at least 2% decrease in VO2 relative 
the traditional shoe were as follows: Nike VF2 (83.3%), Nike AF (75.0%), Asics MS (66.7%), Saucony EP (25.0%), New Bal RC 
(25.0%), Hoka RX (0%), Brooks HE2 (0%). Likewise the percentage of subjects with an at least 3% decrease in VO2 in a given shoe 
were as follows: Nike AF (58.3%), Nike VF2 (50.0%), Asics MS (25.0%), Saucony EP (0 %), New Bal RC (0%), Hoka RX (0%), 
Brooks HE2 (0%). Lastly, 4 of the 12 subjects (25%) responded with a greater than 4% reduction in VO2 in the Nike AF. The Asics 
MS was the only other shoe to have anyone respond with a 4% improvement, limited to a single subject.  
Table 2 
Running economy and heart rate data for male runners (n = 12) at 16 km‧hr-1 in racing shoes ranked from worst (left) to best (right) 
 Asics HS Hoka RX  Brooks HE2 New Bal RC Saucony EP Asics MS  Nike VF2 Nike AF 
VO2*  
(ml‧kg-1‧min-1) 
51.71 ± 2.02‡ 51.67 ± 2.07‡ 51.42 ± 1.72‡ 50.99 ± 1.83†‡ 50.93 ± 1.82†‡ 50.39 ± 1.71† 50.29 ± 1.72† 50.13 ± 1.86† 
O2COT*  
(ml‧kg-1‧km-1) 
193.9 ± 7.6‡ 193.7 ± 7.8‡ 192.8 ± 6.5‡ 191.2 ± 6.9†‡ 191.0 ± 6.8†‡ 189.0 ± 6.4† 188.6 ± 6.5† 188.0 ± 7.0† 
Energetic Cost*  
(w‧kg-1) 
17.74 ± 0.78‡ 17.72 ± 0.77‡ 17.63 ± 0.66‡ 17.48 ± 0.71†‡ 17.44 ± 0.71†‡ 17.24 ± 0.66† 17.21 ± 0.65† 17.16 ± 0.67† 
Heart Rate* 
(beats‧min-1) 
167.6 ± 11.4‡ 167.3 ± 11.4‡ 166.9 ± 11.4 165.6 ± 11.4† 166.6 ± 11.6 165.4 ± 11.7† 165.2 ± 11.7† 164.4 ± 12.1† 
All data represented as mean ± standard deviation. *p < .001 across shoe condition. †sig. difference from Asics HS. ‡ sig. difference from Nike VF2. 
Abbreviations: AF = Alphafly; Bal RC = Balance RC Elite; EP = Endorphin Pro; HE2 = Hyperion Elite 2; HS = Hyperspeed; MS = Metaspeed Sky; O2COT 
= oxygen cost of transport; RX = Rocket X; VF2 = Vaporfly 2; VO2 = oxygen consumption.  
 





Oxygen consumption (ml·kg-1·min-1) across shoe conditions (mean ± SD) at 16 km‧hr-1 with pairwise comparisons showing percent differences and effect sizes 
n = 12 
Asics HS 
51.71 ± 2.02 
Hoka RX 
51.67 ± 2.07 
Brooks HE2 
51.42 ± 1.72 
New Bal RC 
50.99 ± 1.83 
Saucony EP 
50.93 ± 1.82 
Asics MS 
50.39 ± 1.71 
Nike VF2 
50.29 ± 1.72 
Hoka RX 
51.67 ± 2.07 
-0.08 ± 1.04 % 
dz: 0.08 
p = 1.000 
      
Brooks HE2 
51.42 ± 1.72 
-0.53 ± 0.90 % 
dz:0.61 
p = 0.420 
-0.44 ± 1.13 % 
dz: 0.41 
p = 1.000 
     
New Bal RC 
50.99 ± 1.83 
-1.37 ± 0.78 % 
dz: 1.69 
p = 0.002* 
-1.28 ± 1.19 % 
dz: 1.04 
p = 0.035* 
-0.84 ± 0.78 % 
dz: 1.07 
p = 0.035* 
    
Saucony EP 
50.93 ± 1.82 
-1.48 ± 0.72 % 
dz: 2.00 
p < 0.001* 
-1.39 ± 1.20 % 
dz: 1.15 
p = 0.026* 
-0.96 ± 0.51 % 
dz: 1.89 
p < 0.001*  
-0.11 ± 0.58 % 
dz: 0.20 
p = 1.000 
   
Asics MS 
50.39 ± 1.71 
-2.52 ± 1.08 % 
dz: 2.17 
p < 0.001* 
-2.43 ± 1.55 % 
dz: 1.48 
p = 0.005* 
-2.01 ± 1.08 % 
dz:1.82 
p = 0.001* 
-1.17 ± 0.93 % 
dz: 1.22 
p = 0.019* 
-1.06 ± 0.98 % 
dz: 1.06 
p = 0.035* 
  
Nike VF2 
50.29 ± 1.72 
-2.72 ± 1.02 % 
dz: 2.53 
 p < 0.001* 
-2.63 ± 1.30% 
dz: 1.93 
p < 0.001* 
-2.20 ± 0.62 % 
dz: 3.59 
p < 0.001* 
-1.36 ± 0.99 % 
dz: 1.35 
p = 0.010* 
-1.25 ± 0.64 % 
dz: 1.94 
p < 0.001*  
-0.19 ± 0.96 % 
dz: 0.20 
p = 1.000 
 
Nike AF 
50.13 ± 1.86 
-3.03 ± 1.48 % 
dz: 2.01 
p < 0.001* 
-2.94 ± 1.60 % 
dz: 1.80 
p = 0.001* 
-2.51 ± 1.31 % 
dz:1.94 
p < 0.001* 
-1.68 ± 1.48 % 
dz: 1.12 
p = 0.028* 
-1.57 ± 1.33 % 
dz: 1.18 
p = 0.024* 
-0.51 ± 1.24 % 
dz: 0.41 
p = 1.000 
-0.32 ± 1.10 % 
dz: 0.29 
p = 1.000 
Data represented as percentage difference (mean ± SD) between column and row shoe conditions. Cohen’s dz within subject effect size. p-value with Holm 
adjustment for multiple pairwise comparisons of VO2 between shoes.  
Abbreviations: AF = Alphafly; Bal RC = Balance RC Elite; EP = Endorphin Pro; HE2 = Hyperion Elite 2; HS = Hyperspeed; MS = Metaspeed Sky; RX = 
Rocket X; VF2 = Vaporfly 2. 
 




There was no relationship between metabolic cost and shoe mass (r2 = 0.0118). Complete running mechanics data is shown in 
Table 4. Pearson correlations between the average VO2 and the running mechanics variables for a given shoe showed significant 
relationships for the following variables: cadence: r(6) = 0.729, p = 0.040, stride length: r(6) = -0.716, p = 0.046, vertical oscillation: 
r(6) = -0.747, p = 0.033. We attempted to explore some of the individual subject responsiveness by assessing the relationship in 
percent change in VO2 relative to the various running mechanics variables for the three top shoes (Asics MS, Nike AF, Nike VF2). 
However, we did not find any meaningful relationships (r2 < .25, data excluded for brevity). This is likely because the majority of our 
subjects responded well to these top three shoes. 
Table 4  
Running mechanics data for male runners (n = 12) at 16 km‧hr-1 in 7 carbon-plated shoes and 1 traditional shoe. 
 Hoka RX Saucony EP Nike AF Asics MS Nike VF2 New Bal RC Brooks HE2 Asics HS p 
Contact Time  
(ms) 
204 ± 9 205 ± 9 206 ± 9 206 ± 9† 205 ± 8 204 ± 10 203 ± 9 204 ± 9 .001* 
Cadence  
(steps‧min-1) 
175.8 ± 10.5 175.5 ± 10.3 174.6 ± 10.4† 175.5 ± 10.5 175.8 ± 10.3 175.7 ± 10.8 176.1 ± 10.6 176.5 ± 10.3 < .001* 
Stride Length  
(m) 
3.04 ± 0.18 3.05 ± 0.18 3.06 ± 0.18† 3.05 ± 0.18 3.04 ± 0.18 3.05 ± 0.19 3.04 ± 0.18 3.03 ± 0.18 < .001* 
Vertical Osc. 
(cm) 
10.0 ± 1.7 10.0 ± 1.7 10.2 ± 1.7 10.1 ± 1.7 10.0 ± 1.7 10.0 ± 1.7 10.0 ± 1.7 9.9 ± 1.6 .062 
Vertical Osc. 
Ratio (%) 
6.55 ± 0.77 6.56 ± 0.75 6.60 ± 0.76 6.58 ± 0.78 6.54 ± 0.76 6.56 ± 0.77 6.54 ± 0.75 6.53 ± 0.74 .398 
Contact Time 
Imbalance (%) 
2.0 ± 1.9 2.0 ± 1.9 1.8 ± 1.7 2.0 ± 2.1 2.0 ± 1.9 1.8 ± 2.1 1.7 ± 2.0 2.0 ± 2.3 .377 
All data represented as mean ± standard deviation. *p < .05 across shoe condition. †sig. difference from Asics HS.  
Abbreviations: AF = Alphafly; Bal RC = Balance RC Elite; EP = Endorphin Pro; HE2 = Hyperion Elite 2; HS = Hyperspeed; MS = Metaspeed Sky; Osc. = 
oscillation; RX = Rocket X; VF2 = Vaporfly 2 




In fact, there were only three subjects who showed a less than 2% reduction in VO2 on 
average for the Nike VF, Asics MS, and Nike AF relative to the traditional Asics HS. That is not 
to say there was not a range of responsiveness, as subjects ranged from 1% to 4% improvement 
in economy on average. The metabolic and mechanic characteristics of the top 50% of 
responders in terms of economy improvements and the lower 50% of responders is provided in 
Table 5. While the purpose and design of the study was not to make statistical conclusions for 
these types of comparisons, these descriptives do allow for some subsequent points of 
discussion. 
Table 5 
Metabolic and mechanics characteristics of high and low responders 
 Asics HS Top 3 Shoes % Difference 
VO2 (ml‧kg-1‧min-1) Upper 50 52.8 ± 2.0 50.9 ± 1.8 -3.6 ± 0.3 
VO2 (ml‧kg-1‧min-1) Lower 50 50.7 ± 1.5 49.7 ± 1.6 -1.9 ± 0.7 
Contact Time (ms) Upper 50 201 ± 8 202 ± 8 0.8 ± 1 
Contact Time (ms) Lower 50 208 ± 8 209 ± 9 0.4 ± .4 
Cadence (steps‧min-1) Upper 50 174.0 ± 5.4 172.6 ± 5.2 -0.8 ± 0.9 
Cadence (steps‧min-1) Lower 50 179.0 ± 13.8 178.1 ± 13.9 -0.5 ± 0.5 
Vertical Oscillation (cm) Upper 50 10.4 ± 1.3 10.6 ± 1.2 1.9 ± 3.3 
Vertical Oscillation (cm) Lower 50 9.5 ± 2.0 9.6 ± 2.1 1.0 ± 1.2 
All data represented as mean ± standard deviation. Upper 50: top 50% of responders (n=6) in terms of 
economy improvements. Lower 50: bottom 50% of responders (n=6).  
Abbreviations: HS = Hyperspeed; Top 3 = Average of Asics Metaspeed Sky, Nike Vaporfly 2, and Nike 
Alphafly; VO2 = oxygen consumption.  
 
Friedman test revealed significant differences across shoes for all of the subjective survey 
variables (softness/cushioning, energy return, stiffness/rigidity, 5 km race preference, marathon 
race preference). However, post hoc comparisons revealed that only the Nike AF, Nike VF2, and 
Asics MS differed in their energy return rating, stiffness/rigidity rating, and marathon shoe 
preference compared to the Asics HS. The Nike VF2 and Asics MS were more preferred relative 
to the Asics HS for 5 km race preference. Spearman correlations comparing the VO2 rankings of 
the shoes to the subjective survey variable rankings were significant for all variables, but the 




relationship with softness/cushioning: rs(6) = 0.952, p = 0.001 and energy return: rs(6) = 0.929, p 
= 0.002 was stronger than stiffness/rigidity: rs(6) = 0.810, p = 0.022. Likewise, marathon shoe 
preference: rs(6) = 0.905, p = 0.005 was more strongly related to the VO2 rankings than 5 km 
shoe preference: rs(6) = 0.833, p = 0.015. 
RER (0.92 ± 0.04) remained below 1.0 for all subjects across the trials. Blood lactate 
recorded at the conclusion of testing protocol (2.1 ± 0.9 mmol‧L-1) was ≤ 4 mmol‧L-1 for all 
subjects. Additionally, to confirm that there was not a substantial VO2 slow component we 
examined the average VO2 at minute 4 (50.8 ± 1.9 ml‧kg
-1‧min-1) to minute 5 (51.0 ± 1.8 ml‧kg-
1‧min-1) across all trials, which represented only a 0.39 ± 0.49% difference. We used an ANOVA 
to examine whether or not there were differences in VO2 based on shoe testing sequence and 
found no differences (p = 0.946), indicating that the randomization and mirrored design was 
effective. 
4. Discussion 
 Our findings are unique as this is the first study to our knowledge to compare RE 
between the previously established Nike Vaporfly shoe to other competitor shoes also utilizing 
carbon-fiber plates and thicker midsole foams. On average, RE was improved by 2.7% in the 
Nike VF2 relative to the traditional shoe in the present study. However, only the Nike AF (3.0%) 
and Asics MS (2.5%) resulted in similar improvements in RE. And while other shoes in the 
lineup did perform statistically better than the traditional (Asics HS) shoe, none resulted in 
greater than 1.5% improvements on average. These data suggest that the release of new “super” 
shoes by various brands across the running shoe industry has not resulted in a leveling of the 
playing field relative to the established Nike shoes. It is evident from our data that simply 
including a carbon plate or increasing the stack height in a racing shoe does not confer equal 




improvements in economy. This would suggest that the foam and/or interaction of the foam and 
the plate is crucial to the economy benefits. This is consistent with recent findings by Healey and 
Hoogkamer,24 who showed that cutting the carbon plate in the Nike VF to reduce the 
longitudinal bending stiffness did not result in changes in RE compared to an intact version of 
the Nike VF, suggesting that the PEBA based ZoomX foam in the Nike VF is the critical factor. 
This also helps to explain the equivocal findings in the literature on the effects of increasing 
longitudinal bending stiffness on RE, as pointed out in recent reviews.25, 26 Despite the 
widespread use of carbon-fiber plates in new racing shoes, the foam technology still varies 
widely. Additionally due to the use of proprietary foam names and blends, it is difficult to 
determine exactly what midsole foams are composed of (EVA, TPU, PEBA, etc.) across 
different shoe brands. Even when shoes are known to utilize similar foam materials, such as the 
case with the PEBA based Saucony EP and Nike VF2/AF, we see differences in economy in the 
current study.  
In regards to the magnitude of improvement in RE in these new shoes, our findings show 
the Asics MS (2.5%, range 0.9-4.9%), Nike VF2 (2.7%, range 0.8-3.8%), Nike AF (3%, range 0-
5.3%) all improved economy to a similar extent relative to a traditional racing shoe. In the 
current study the traditional racing shoe utilized (Asics HS) was heavier than the Asics MS 
(+18g) and Nike VF2 (+16g), but lighter than the Nike AF (-13g). Previously, Barnes and 
Kilding8 found that relative to a traditional racing shoe (Adidas Adios Boost) the Nike VF 
improved economy by 4.2% at 16 km‧hr-1, though this advantage was reduced to 2.9% when 
~30-35 g was added to the Nike VF shoe to equal the mass of the traditional racing shoe. 
Although this reduction in economy of greater than 1% is more than would be expected for this 
minimal amount of additional mass, these mass adjusted improvements are similar to our current 




findings. This is somewhat in contrast to the magnitude of response found by Hoogkamer et al.7 
who showed 4% improvements in economy with a Nike VF prototype even when ~50g of 
additional mass was added to the Nike VF to equal the mass of the traditional shoe. And finally, 
Hunter et al.9 showed only 2.8% improvements in the Nike VF when compared to the same 
control shoe that was ~35g heavier.   
Traditionally, shoe mass has been inversely related to RE. It has previously been 
proposed for typical running shoes that for every 100 g increase in shoe mass, oxygen cost 
increases by ~1%.27 This may no longer be the case given the new materials being incorporated 
into racing shoes. For instance, Barnes and Kilding8 showed that the Nike VF improved 
economy by 2.6% compared to a track spike, despite being nearly 100g heavier. We chose not to 
match for shoe mass in the present study for several reasons. 1) All of the shoes tested ranged in 
mass by a fairly narrow range (~30 g), and all shoes were within 18 g of the traditional shoe 
being compared. 2) Given the multitude of shoes tested this would have required entirely 
separate lab visits for mass-matched trials. 3) We did not see a relationship between shoe mass 
and oxygen cost. 4) Of the shoes that offered substantive benefits to RE, the heaviest shoe in the 
lineup (Nike AF: 240 g) was the most economical and performed similarly to the lightest shoes 
(Nike VF2: 211 g, Asics MS: 209 g). 5) And finally, from an external validity standpoint, we 
contend that not matching for shoe mass has greater application. Simply adding extra inert mass, 
not in the form of extra foam, does not seem useful or practical. Given that these new shoes have 
been engineered with thicker foam with the goal of enhancing energy return, there is a tradeoff 
manufacturers face between adding more “springy” material vs. keeping the shoe lighter. While 
this tradeoff is something that a given shoe manufacturer would need to explore in the 
development of a shoe, when it comes to real world application, an athlete is most concerned 




simply with what shoe enhances economy the most among a similar, competitive, lineup of 
racing shoe options. This is what we have proposed and compared in the current lineup of shoes 
tested. 
While the Nike VF2, Nike AF, and Asics MS were the top three shoes in the study in 
terms of improving RE, we only found a few significant differences between these shoes and the 
traditional Asics HS shoe in terms of running mechanics (Table 4). Ground contact time was 
greater in the Asics MS, cadence was lower in the Nike AF, and stride length was longer in the 
Nike AF. These trends however are consistent with the previously studied Nike VF.7, 8 
Furthermore, significant Pearson correlations in the present study showed that the average VO2 
across shoes was directly related to the average cadence and inversely related to average vertical 
oscillation and stride length. This suggests that a shoe’s effectiveness in improving economy is 
likely related to such changes in mechanics, characterized by longer, bouncier strides. 
In regards to individual subject responsiveness, we provided some descriptive metabolic 
and mechanics characteristics of high and low responders (Table 5). From these data it appears 
that the subjects who are more responsive (indicated by greater percent reductions in VO2) are 
less economical to begin with in traditional shoes, as shown by the greater VO2 when running in 
the Asics HS. In this sense, it appears that the top shoes are allowing the less economical runners 
to close the gap in economy advantages relative to their more economical competitors. We also 
see that cadence tends to be higher and vertical oscillation lower in the low responders. It is 
unclear if this is simply a characteristic of them being more efficient runners to begin with, or if 
these characteristics might impact the responsiveness to the new shoes. The 4 subjects who were 
the lowest responders in terms of VO2 improvement (0-2.2%) in the Nike AF, had the 4 highest 
cadences in the study, average 186 steps‧min-1 compared to 170 steps‧min-1 for the remainder of 




the participants. Vertical oscillation was also lower in these participants (8.48 cm) compared to 
the remainder of the subjects (10.77 cm). In fact, the only subject who was a complete non-
responder to the Nike AF (0% improvement) was the only runner in the study who had a vertical 
oscillation of less than 8 cm. These things considered, we would speculate that low- or non-
responders on an individual level, although rare, might be a result of naturally low vertical 
oscillation and high cadence running that is already considered economical,2 but more 
importantly may not allow for the full energy saving benefit of these “springier” shoes to be 
realized. While we did not examine foot strike patterns, Hoogkamer et al.7 did show that rearfoot 
strikers who ran with longer ground contact times and lower cadences (~173 steps‧min-1) tended 
to respond better to the Nike VF than faster cadence (~180 steps‧min-1) mid/forefoot strikers. 
However, future studies would need to be designed specifically for separating out high 
cadence/low vertical oscillation “shufflers” from low cadence/high vertical oscillation 
“bounders” to truly make these comparisons. 
Given the difficulty in testing every new shoe available and the lack of access for most 
athletes to perform individualized RE testing, we attempted to explore if any subjective measures 
related to a shoe’s RE. While we saw moderate to strong relationships across all variables, it 
appears that the group rankings on the softness/cushioning and energy return of the shoes was 
more closely related to the average VO2 in the shoes than was the stiffness/rigidity rating. This 
seems reasonable as the carbon plate in the shoes likely imparts similar subjective feelings of 
stiffness/rigidity, but the various foam materials have a broader range of ratings and are likely 
more important to the economy improvements. Furthermore, marathon shoe preference ranking 
was more closely related to VO2 ranking of the shoes than 5k shoe preference ranking. It is likely 
that runners simply gravitated to the lighter shoes when thinking about racing a 5k, but this is not 




necessarily in the best interest in terms of RE, as seen in the heavier, but more economical Nike 
AF. It is important to note that these Spearman ranked correlations were based on the group 
averages and do not necessarily indicate that on the individual level athletes were effective at 
rating which shoe would be best for them. In fact, only 2 of 12 subjects (5 km shoe preference) 
and 3 of 12 subjects (marathon shoe preference) selected the shoe that was most economical for 
them individually. While our study was not designed to draw broad conclusions on these 
subjective measures, the group average relationships may help shed some insight in parsing 
through the abundance of subjective shoe reviews that can be found online and help guide more 
robust investigations in this area.  
Future research should continue to establish whether or not new racing shoes are 
comparable with the Nike VF, and the now established Nike AF and Asics MS. As far as the 
speeds at which these shoes might help improve economy, our study was delimited to 16 km·hr-
1. However, based on previous research,8 similar benefits would be expected from at least 14 to 
18 km·hr-1. Future investigations can help elucidate the minimum speeds at which these shoes no 
longer confer meaningful benefits, as well as help to clarify characteristics of runners likely to be 
low- or non-responders. Lastly, future research can help to determine if there are benefits 
(decreased muscle damage, soreness, etc.) offered by these new shoe advancements that aid 
performance beyond that of the observed improvements in RE.   
5. Conclusions 
Based on our findings indicating that only the Asics MS and Nike AF offered similar RE 
improvements as the Nike VF2, we conclude the current competitive running shoe market is not 
equal and athletes choosing to race in any of the shoes shown to be inferior to these in the 
present lineup are likely at a competitive disadvantage. For perspective, the 2.5-3% improvement 




on average for the Nike AF, Nike VF2, and Asics MS is similar to or greater than the expected 
improvements in RE in response to several weeks to months of various plyometric or resistance 
training interventions.28 Using the equation developed by Tam et al.29 as previously described 
and applied,30 a 3% improvement in RE would be expected to improve performance by ~3% at 
14 km‧hr-1 and ~2.6% at 20 km‧hr-1. This would theoretically translate to ~25-30 seconds for a 
15-17 minute 5-km runner and ~4-6 minutes for a 2.5-3.5 hour marathon runner. With this in 
mind, we would suggest the following to running shoe industry stakeholders. 1) If shoe 
companies wish for consumers to believe that their new technological advancements offer 
performance benefits, they should support independent testing of their products. 2) Consumers 
should be wary of paying high prices for “advanced” shoes that have not been proven to offer 
comparable benefits to the presently established shoes. 3) Elite athletes, and sub-elite athletes 
with access, should seek laboratory based RE testing before making decisions on racing shoes, 
particularly those that have not been independently tested. 4) Sport governing bodies should 
remain vigilant in assessing whether the competitive shoe market becomes more level over time.  
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